Propranolol and mesenchymal stromal cells combine to treat traumatic brain injury

Stem Cells Translational Medicine

Volumn 5, Issue 1, 2016, Pages 33-44

  Kota, Daniel J ^a   Prabhakara, Karthik S ^a   Van Brummen, Alexandra J ^a   Bedi, Supinder ^a   Xue, Hasen ^a   DiCarlo, Bryan ^a   Cox, Charles S ^a   Olson, Scott D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Mesenchymal stromal cell; Propranolol; Traumatic brain injury; Blocker

Indexed keywords

NORADRENALIN; PROPRANOLOL;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; BONE MARROW BIOPSY; BRAIN EDEMA; CELL CULTURE; CLINICAL TRIAL (TOPIC); COGNITION; CONTROLLED STUDY; EDEMA; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MEMORY; MESENCHYMAL STROMA CELL; MICROGLIA; MORRIS WATER MAZE TEST; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; SPATIAL LEARNING; TRAUMATIC BRAIN INJURY; ALLOGRAFT; ANIMAL; BONE MARROW CELL; BRAIN INJURIES; DRUG EFFECTS; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADULT; ALLOGRAFTS; ANIMALS; BONE MARROW CELLS; BRAIN INJURIES; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROGLIA; NEUROGENESIS; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84954460896     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0065     Document Type: Article

References (83)

1. Gean AD, Fischbein NJ. Head trauma. Neuroimaging Clin N Am 2010;20:527-556.
2. Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: Emergency department visits, hospitalizations, and deaths. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010.
3. Finkelstein ECP, Miller T. The Incidence and Economic Burden of Injuries in theUnited States. New York, NY: Oxford University Press, 2006.
4. Moppett IK. Traumatic brain injury: Assessment, resuscitation and earlymanagement. Br J Anaesth 2007;99:18-31.
5. Kumar A, Loane DJ. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 2012;26:1191-1201.
6. McIntosh TK, Smith DH, Meaney DF et al. Neuropathological sequelae of traumatic brain injury: Relationship to neurochemical and biomechanical mechanisms. Lab Invest 1996;74:315-342.
7. Cox CS Jr., Baumgartner JE, Harting MT et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery 2011;68:588-600.
8. Margulies S, Hicks R. Combination therapies for traumatic brain injury: Prospective considerations. J Neurotrauma 2009;26:925-939.
9. Stoica B, Byrnes K, Faden AI. Multifunctional drug treatment in neurotrauma. Neurotherapeutics 2009;6:14-27.
10. Cotton BA, Snodgrass KB, Fleming SB et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma 2007;62:26-35.
11. Foley N, Marshall S, Pikul J et al. Hypermetabolism following moderate to severe traumatic acute brain injury: A systematic review. J Neurotrauma 2008;25:1415-1431.
12. Heffernan DS, Inaba K, Arbabi S et al. Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy. J Trauma 2010;69:1602-1609.
13. Ker K, Blackhall K. Beta-2 receptor antagonists for acute traumatic brain injury. Cochrane Database Syst Rev 2008;CD006686.
14. Ley EJ, Clond MA, Bukur M et al. b-Adrenergic receptor inhibition affects cerebral glucosemetabolism, motor performance, and inflammatory response after traumatic brain injury. J Trauma Acute Care Surg 2012;73:33-40.
15. Ley EJ, Scehnet J, Park R et al. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma 2009;66:154-161.
16. RiordanWPJr., Cotton BA, NorrisPR et al. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma 2007;63:503-511.
17. Tran TY, Dunne IE, German JW. Beta blockers exposure and traumatic brain injury: A literature review. Neurosurg Focus 2008;25: E8.
18. Schroeppel TJ, Sharpe JP, Magnotti LJ et al. Traumatic brain injury and b-blockers: Not all drugs are created equal. J Trauma Acute Care Surg 2014;76:504-509.
19. Patel MB, McKenna JW, Alvarez JM et al. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): Study protocol for a randomized controlled trial. Trials 2012;13:177.
20. Bauer G, Dao MA, Case SS et al. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Mol Ther 2008;16:1308-1315.
21. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 2012;20:14-20.
22. Wang Y, Chen X, CaoWet al. Plasticity of mesenchymal stem cells in immunomodulation: Pathological and therapeutic implications. Nat Immunol 2014;15:1009-1016.
23. Gentleman SM, Leclercq PD, Moyes L et al. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 2004;146:97-104.
24. Johnson VE, Stewart JE, Begbie FD et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 2013;136:28-42.
25. Ramlackhansingh AF, Brooks DJ, Greenwood RJ et al. Inflammation after trauma: Microglial activation and traumatic brain injury. Ann Neurol 2011;70:374-383.
26. Zhang R, Liu Y, Yan K et al. Antiinflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 2013;10:106.
27. Ren G, Su J, Zhang L et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. STEM CELLS 2009;27:1954-1962.
28. Lee JM, Jung J, Lee HJ et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bonemarrow and adipose mesenchymal stem cells. Int Immunopharmacol 2012;13:219-224.
29. Puissant B, Barreau C, Bourin P et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005;129:118-129.
30. Ribeiro A, Laranjeira P, Mendes S et al. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther 2013;4:125.
31. Yoo KH, Jang IK, Lee MW et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 2009;259:150-156.
32. Lee RH, Yu JM, FoskettAMet al. TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proc Natl Acad Sci USA 2014;111:16766-16771.
33. Bedi SS, Hetz R, Thomas C et al. Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. STEM CELLS TRANSLATIONAL MEDICINE 2013;2:953-960.
34. Sekiya I, Larson BL, Smith JR et al. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. STEM CELLS 2002;20:530-541.
35. Walker PA, Bedi SS, Shah SK et al. Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: Modulation of the resident microglia population. J Neuroinflammation 2012;9:228.
36. Liao GP, Olson SD, Kota DJ et al. Far-red tracer analysis of traumatic cerebrovascular permeability. J Surg Res 2014;190:628-633.
37. Bedi SS, Walker PA, Shah SK et al. Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. J Trauma Acute Care Surg 2013;75:410-416.
38. Ley EJ, Park R, Dagliyan G et al. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma 2010;68:353-356.
39. Liu MY. Protective effects of propranolol on experimentally head-injured mouse brains. J Formos Med Assoc 1995;94:386-390.
40. Shlosberg D, Benifla M, Kaufer D et al. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010;6:393-403.
41. Loane DJ, Faden AI. Neuroprotection for traumatic brain injury: Translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 2010;31:596-604.
42. Csuka E, Hans VH, Ammann E et al. Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport 2000;11:2587-2590.
43. Engel S, Schluesener H, MittelbronnMet al. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 andMRP14.ActaNeuropathol2000;100:313-322.
44. Gage FH. Mammalian neural stem cells. Science 2000;287:1433-1438.
45. McKay R. Stem cells in the central nervous system. Science 1997;276:66-71.
46. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J Neurosci 1996;16:2027-2033.
47. Couillard-Despres S, Winner B, Schaubeck S et al. Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci 2005;21:1-14.
48. Herndon DN, Hart DW, Wolf SE et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001;345:1223-1229.
49. Bareyre F, Wahl F, McIntosh TK et al. Time course of cerebral edema after traumatic brain injury in rats: Effects of riluzole and mannitol. J Neurotrauma 1997;14:839-849.
50. Unterberg AW, Stover J, Kress B et al. Edema and brain trauma. Neuroscience 2004; 129:1021-1029.
51. Hörtnagl H, Hammerle AF, Hackl JM et al. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med 1980;6:169-177.
52. Trouche E, Mias C, Seguelas MH et al. Characterization of monoamine oxidases in mesenchymal stem cells: Role in hydrogen peroxide generation and serotonin-dependent apoptosis. Stem Cells Dev 2010;19:1571-1578.
53. Kotova PD, Sysoeva VY, Rogachevskaja OA et al. Functional expression of adrenoreceptors in mesenchymal stromal cells derived from the human adipose tissue. Biochim Biophys Acta 2014;1843:1899-1908.
54. Benveniste EN. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 1998;9:259-275.
55. Rodríguez-Baeza A, Reina-de la Torre F, Poca A et al. Morphological features in human cortical brain microvessels after head injury: A three-dimensional and immunocytochemical study. Anat Rec A Discov Mol Cell Evol Biol 2003;273:583-593.
56. Menge T, Zhao Y, Zhao J et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Sci Transl Med 2012;4:161ra150.
57. Chen M, Li X, Zhang X et al. The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: Contribution of TSG-6. J Neuroinflammation 2015;12:61.
58. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009;5:54-63.
59. Choi H, Lee RH, Bazhanov N et al. Antiinflammatory proteinTSG-6 secretedbyactivated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kB signaling in resident macrophages. Blood 2011;118:330-338.
60. Morganti-Kossmann MC, Satgunaseelan L, Bye N et al. Modulation of immune response by head injury. Injury 2007;38:1392-1400.
61. Graeber MB. Changing face of microglia. Science 2010;330:783-788.
62. Nicholas RS, Wing MG, Compston A. Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-kappa B. Eur J Neurosci 2001;13:959-967.
63. Walton NM, Sutter BM, Laywell ED et al. Microglia instruct subventricular zone neurogenesis. Glia 2006;54:815-825.
64. Ooi YY, Ramasamy R, Rahmat Z et al. Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide. Int Immunopharmacol 2010;10: 1532-1540.
65. Yan K, Zhang R, Sun C et al. Bone marrowderived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation. PLoS One 2013;8:e84116.
66. Liu Y, Zhang R, Yan K et al. Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6. J Neuroinflammation 2014;11:135.
67. Bregy A, Nixon R, Lotocki G et al. Posttraumatic hypothermia increases doublecortin expressing neurons in the dentate gyrus after traumatic brain injury in the rat. Exp Neurol 2012;233:821-828.
68. Acosta SA, DiamondDM, Wolfe S et al. Influence of post-traumatic stress disorder on neuroinflammation and cell proliferation in a rat model of traumatic brain injury. PLoS One 2013;8:e81585.
69. Yu TS, Zhang G, Liebl DJ et al. Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors. J Neurosci 2008;28:12901-12912.
70. Eriksson PS, Perfilieva E, Björk-Eriksson T et al. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-1317.
71. Calzarossa C, Bossolasco P, Besana A et al. Neurorescue effects and stem properties of chorionic villi and amniotic progenitor cells. Neuroscience 2013;234:158-172.
72. Nakano N, Nakai Y, Seo TB et al. Characterization of conditioned medium of cultured bone marrow stromal cells. Neurosci Lett 2010;483:57-61.
73. Teixeira FG, Carvalho MM, Sousa N et al. Mesenchymal stem cells secretome: A new paradigm for central nervous system regeneration? Cell Mol Life Sci 2013;70:3871-3882.
74. Wilkins A, Kemp K, GintyMet al. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res (Amst) 2009;3:63-70.
75. Bai L, Caplan A, Lennon D et al. Human mesenchymal stem cells signals regulate neural stem cell fate. Neurochem Res 2007;32: 353-362.
76. Lee H, Kang JE, Lee JK et al. Bone-marrowderived mesenchymal stem cells promote proliferation and neuronal differentiation of Niemann-Pick type C mouse neural stem cells by upregulation and secretion of CCL2. Hum Gene Ther 2013;24:655-669.
77. Whitney NP, Eidem TM, Peng H et al. Inflammation mediates varying effects in neurogenesis: Relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 2009;108:1343-1359.
78. Maxwell WL, MacKinnon MA, Smith DH et al. Thalamic nuclei after human blunt head injury. J Neuropathol Exp Neurol 2006;65: 478-488.
79. Grossman EJ, Ge Y, Jensen JH et al. Thalamus and cognitive impairment in mild traumatic brain injury: A diffusional kurtosis imaging study. J Neurotrauma 2012;29: 2318-2327.
80. Little DM, Kraus MF, Joseph J et al. Thalamic integrity underlies executive dysfunction in traumatic brain injury. Neurology 2010; 74:558-564.
81. Schiff ND, Giacino JT, Kalmar K et al. Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature 2007;448:600-603.
82. Belarbi K, Jopson T, Tweedie D et al. TNF-a protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation 2012;9:23.
83. Darlington PJ, Boivin MN, Bar-Or A. Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis. Expert Rev Neurother 2011;11:1295-1303.